How Did Institut Pasteur’s NGS Core Facility, Biomics, Manage the Coronavirus Disease 2019 Crisis?
| Autor: | Laurence Ma, Valérie Briolat, Imène Najjar, Marc Monot, Laure Lemée, Laurence Motreff |
|---|---|
| Přispěvatelé: | Pôle Biomics (C2RT), Centre de Ressources et de Recherche Technologique - Center for Technological Resources and Research (C2RT), Institut Pasteur [Paris]-Institut Pasteur [Paris], The Biomics platform is supported by France Génomique (ANR-10-INBS-09-09) and Infrastructures en Biologie, Santé et Agronomie (IBiSA). This work was supported by the 'URGENCE COVID-19' fundraising campaign of IP., We thank the other members of Biomics who made it possible for the activities of the platform to continue during lockdown: Julian Garneau, Elodie Turc, George Haustant, Zachary Allouche, Thomas Cockelear, Juliana Pipoli Da Fonseca, and Etienne Kornobis. We would particularly like to thank our collaborator from the IP of Tunis Sadri Znaidi and the C2RT Head of Operations Anna Kheres for taking the time to read the manuscript and for giving recommendations and advice. The authors declare no conflicts of interest., ANR-10-INBS-0009,France-Génomique,Organisation et montée en puissance d'une Infrastructure Nationale de Génomique(2010), Institut Pasteur [Paris] (IP)-Institut Pasteur [Paris] (IP) |
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Paris
MESH: Pandemics Process management Quality management [SDV]Life Sciences [q-bio] coronavirus Risk management information systems Crisis management Article MESH: Communicable Disease Control Business continuity Added value Humans MESH: COVID-19 MESH: SARS-CoV-2 Pandemics Molecular Biology MESH: High-Throughput Nucleotide Sequencing MESH: Humans Emergency management business.industry SARS-CoV-2 MESH: Paris COVID-19 High-Throughput Nucleotide Sequencing Benchmarking OMICS sequencing 3. Good health Core Facility NGS Communicable Disease Control MESH: Laboratories Business Laboratories management |
| Zdroj: | Journal of Biomolecular Techniques Journal of Biomolecular Techniques, Association of Biomolecular Resource Facilities, 2021, 32 (2), pp.jbt.21-3202-004. ⟨10.7171/jbt.21-3202-004⟩ Journal of Biomolecular Techniques, 2021, 32 (2), pp.jbt.21-3202-004. ⟨10.7171/jbt.21-3202-004⟩ J Biomol Tech |
| ISSN: | 1524-0215 |
| DOI: | 10.7171/jbt.21-3202-004⟩ |
| Popis: | International audience; In 2020, research entities at the Institut Pasteur (IP) in Paris, as elsewhere around the world, were closed because of the coronavirus disease 2019 (COVID-19) pandemic. However, IP core facilities, laboratories, services, and departments working on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and priority projects were authorized to continue working both on site and remotely. Given the importance of its role in SARS-CoV-2 genome-sequencing initiatives, the IP Biomics core facility was fully functional during the first (i.e., March-June 2020) and second (i.e., November-December 2020) national lockdowns. We describe here how Biomics successfully implemented an emergency management plan to deal with this health crisis. We highlight the internal deployment of the institutional business continuity plan (BCP) through a series of actions. We also address the impact of the COVID-19 crisis on Biomics staff and collaborators. The added value of quality management and the limitations of risk management systems are discussed. Finally, we suggest that the Biomics infrastructure and the BCP described here could be used for benchmarking purposes, for other next-generation sequencing core facilities wishing to implement/improve their processes, and for future major crisis management. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|